IBC Bank to Provide Holiday Dinner for More Than 500 People at Respite Center in McAllen

Breaking NewsCommunity News
239

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

This year, as part of their commitment to “Do More” for the communities in which they serve, IBC Bank-McAllen will provide dinner for more than 500 immigrants and low-income families on Wednesday, December 12 at the Respite Center in Downtown McAllen.

Helping families and individuals in need is what IBC Bank is all about, especially during the holiday season. Once again, IBC Bank will be partnering with Sister Norma Pimental and Catholic Charities of the Rio Grande Valley to feed and give back to individuals and families in the area.

WHEN:            Wednesday, December 12, 2018, 6:00 p.m.

- Advertisement -

WHERE:         Catholic Charities Respite Center

                        209 Hackberry Ave

                        McAllen, TX 78501

WHO:              IBC Bank-McAllen CEO and President Adrian Villarreal

- Advertisement -

                        IBC Bank Senior Vice President Dora Brown

                        Sister Norma Pimental

                        IBC Bank-McAllen Officers and managers

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Congressman Gonzalez Applauds New Medicare Drug Pricing Rule Aimed at Lowering Prescription Drug Prices
Next article
DHR Health Helps Patients in the Rio Grande Valley Take 182,000 Steps with the EksoGT™ Wearable Exoskeleton

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

STHS Children’s Marks 20th Anniversary with Gala Honoring Pediatric Providers Behind Its Success

For the past 20 years, South Texas Health System Children’s has stood as a place where compassionate care and clinical excellence come together to create hope for children and their families.
- Advertisement -